Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arjo ABARRJF -0.52%74 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates ARRJF with a GF Score™ of 74/100 and a GF Value™ of $3.53 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 71 Medical Distribution companies, Arjo AB ranks worse than 1408449.3% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Arjo AB's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Arjo AB's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 13 years, Arjo AB's highest 3-Year Share Buyback Ratio was 0.00%. The lowest was -2.30%. And the median was 0.00%.
ARRJF's 3-Year Share Buyback Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: -0.5 * Ranked among companies with meaningful 3-Year Share Buyback Ratio only.
Arjo AB (OTCPK:ARRJF) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Arjo AB 3-Year Share Buyback Ratio Related Terms
ARRJF vs MCK, COR, CAH: 3-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, Arjo AB's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB 3-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Arjo AB's 3-Year Share Buyback Ratio falls into.
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.00 mean?
Arjo AB (ARRJF) has a 3-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Arjo AB and its competitors. According to the industry distribution chart, Arjo AB ranks #999999 out of 71 companies in the Medical Distribution industry.
Is Arjo AB's 3-Year Share Buyback Ratio too high?
Arjo AB's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Arjo AB ranks #999999 out of 71 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arjo AB has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's 3-Year Share Buyback Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #999999 out of 71 companies for 3-Year Share Buyback Ratio. This places Arjo AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Distribution company?
A good 3-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Arjo AB and its competitors. Arjo AB's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (ARRJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.53, compared to a current price of $2.85 — trading 19.3% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.00. Arjo AB's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Arjo AB (ARRJF), the current 3-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (ARRJF) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of $2.85 is trading 19.3% below its estimated GF Value™ of $3.53.
GuruFocus considers Arjo AB to be Modestly Undervalued.
Key valuation signals for ARRJF:
3-Year Share Buyback Ratio: 0.00
GF Value™: $3.53 vs. price of $2.85 (19.3% below fair value)
No single metric tells the full story. See the ARRJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
74GF Score
Get the complete analysis for ARRJF
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARRJF has been successfully added to your 
